15 research outputs found
PND39 AGREEMENT BETWEEN MULTIPLE SCLEROSIS-RELATED VARIABLES IN MEDICAL CHARTS AND CLAIMS DATA
Get PDFPlatform Therapy Compared with Natalizumab for Multiple Sclerosis: Relapse Rates and Time to Relapse Among Propensity Score-Matched US Patients
Get PDFDifference-in-Differences Method in Comparative Effectiveness Research: Utility with Unbalanced Groups
Get PDFPND39 AGREEMENT BETWEEN MULTIPLE SCLEROSIS-RELATED VARIABLES IN MEDICAL CHARTS AND CLAIMS DATA
No full textTreatment Patterns Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy
No full textOutcomes of Stable Multiple Sclerosis Patients Staying on Initial Interferon Beta Therapy Versus Switching to Another Interferon Beta Therapy: A US Claims Database Study
No full textResource utilization and direct medical costs in adult systemic lupus erythematosus patients from a commercially insured population
No full text
Comparative Effectiveness Research of Disease-Modifying Therapies for the Management of Multiple Sclerosis: Analysis of a Large Health Insurance Claims Database
No full textPersistence with dimethyl fumarate in relapsing-remitting multiple sclerosis: a population-based cohort study
No full text
